Northern Trust’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.27M Sell
71,648
-11,134
-13% -$390K ﹤0.01% 2994
2026
Q2
$2.86M Sell
82,782
-686
-0.8% -$20.8K ﹤0.01% 2925
2026
Q1
$2.36M Buy
83,468
+2,433
+3% +$65K ﹤0.01% 2881
2025
Q4
$2.25M Buy
81,035
+3,080
+4% +$74.2K ﹤0.01% 2931
2025
Q3
$1.94M Sell
77,955
-17,314
-18% -$384K ﹤0.01% 3051
2025
Q2
$1.68M Buy
95,269
+8,393
+10% +$135K ﹤0.01% 3092
2025
Q1
$1.36M Sell
86,876
-5,056
-5% -$85.3K ﹤0.01% 3129
2024
Q4
$1.76M Buy
91,932
+76,188
+484% +$1.57M ﹤0.01% 3098
2024
Q3
$292K Buy
+15,744
New +$288K ﹤0.01% 3752

Other funds holding PHVS

Northern Trust's PHVS Position: Q3 2026 in Review

Northern Trust reduced its Pharvaris (PHVS) stake by 13% in Q3 2026, selling an estimated $390K and leaving 71,648 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2994.

Northern Trust first reported a position in PHVS in Q3 2024 and has held it in 9 quarters since. The position peaked at $2.86M in Q2 2026. 135 funds tracked by Wall St. Rank hold PHVS as of Q3 2026.

  • Northern Trust held 71,648 shares of Pharvaris worth $2.27M as of Q3 2026.
  • Northern Trust sold 11,134 Pharvaris shares in Q3 2026, an estimated $390K.
  • Pharvaris made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #2994 holding.
  • Northern Trust first reported a position in Pharvaris in Q3 2024 and has held it in 9 quarters since.
  • Northern Trust's Pharvaris position peaked at $2.86M in Q2 2026.
  • 135 funds tracked by Wall St. Rank held Pharvaris as of Q3 2026.

Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.